Literature DB >> 29410306

Two-week intervals during omalizumab treatment may provide better symptom control in selected patients with chronic urticaria.

Murat Türk1, Emek Kocatürk2, Kübra Cüre2, İnsu Yılmaz3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29410306     DOI: 10.1016/j.jaip.2018.01.027

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  5 in total

Review 1.  Update on Omalizumab for Urticaria: What's New in the Literature from Mechanisms to Clinic.

Authors:  Désirée E S Larenas-Linnemann; Claudio A S Parisi; Carla Ritchie; Ricardo Cardona-Villa; Ivan Cherrez-Ojeda; Annia Cherrez; Luis Felipe Ensina; Elizabeth Garcia; Iris V Medina; Mónica Rodríguez-González; Jorge Mario Sánchez Caraballo
Journal:  Curr Allergy Asthma Rep       Date:  2018-05-09       Impact factor: 4.806

2.  Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America.

Authors:  Ivan Cherrez-Ojeda; Marcus Maurer; Jonathan A Bernstein; Emanuel Vanegas; Miguel Felix; German D Ramon; Luis Felipe Ensina; José Ignacio Larco Sousa; Edgar Emilio Matos Benavides; R Cardona Villa; P Latour Staffeld; Blanca María Morfin-Maciel; Jose Mori; Paul Wilches C; Valeria L Mata; Annia Cherrez
Journal:  World Allergy Organ J       Date:  2019-02-23       Impact factor: 4.084

3.  A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real-world study in Belgium.

Authors:  H Lapeere; M Baeck; A Stockman; V Sabato; M Grosber; M Moutschen; J Lambert; L Vandebuerie; L de Montjoye; H Rabijns; K Allewaert; R Schrijvers
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-08-19       Impact factor: 6.166

Review 4.  Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy.

Authors:  Harsha H Kariyawasam; Louisa K James
Journal:  Drug Des Devel Ther       Date:  2020-12-10       Impact factor: 4.162

Review 5.  Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence.

Authors:  Martin Metz; Zahava Vadasz; Emek Kocatürk; Ana M Giménez-Arnau
Journal:  Clin Rev Allergy Immunol       Date:  2020-08       Impact factor: 8.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.